138 related articles for article (PubMed ID: 888100)
21. Acute effects of peritoneovenous shunt (Le Veen) on the hemodynamics and gas exchange in patients with hepatic intractable ascites.
Brandi LS; Grana M; D'Elia F; Ferrari M; Oleggini M; Carmellini M; Pietrabissa A; Mosca F
Ital J Surg Sci; 1988; 18(2):137-42. PubMed ID: 3225174
[TBL] [Abstract][Full Text] [Related]
22. Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis.
Orloff MJ; Charters AC; Chandler JG; Condon JK; Grambort DE; Modafferi TR; Levin SE; Brown NB; Sviokla SC; Knox DG
Surg Gynecol Obstet; 1975 Jul; 141(1):59-68. PubMed ID: 1154215
[TBL] [Abstract][Full Text] [Related]
23. [The Denver peritoneojugular shunt. Current indications].
Bracci F; Bracaglia C; Zampino MA; Farina F; Cucchiara G
Minerva Med; 1989 Apr; 80(4):363-6. PubMed ID: 2725937
[TBL] [Abstract][Full Text] [Related]
24. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study.
Castells A; Saló J; Planas R; Quer JC; Ginès A; Boix J; Ginès P; Gassull MA; Terés J; Arroyo V
Hepatology; 1994 Sep; 20(3):584-91. PubMed ID: 8076916
[TBL] [Abstract][Full Text] [Related]
25. Ascites: its correction by peritoneovenous shunting.
LeVeen HH; Wapnick S; Diaz C; Grosberg S; Kinney M
Curr Probl Surg; 1979 Feb; 16(2):1-61. PubMed ID: 371915
[TBL] [Abstract][Full Text] [Related]
26. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
27. Acute kidney injury and hepatorenal syndrome in cirrhosis.
Egerod Israelsen M; Gluud LL; Krag A
J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
[TBL] [Abstract][Full Text] [Related]
28. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
29. [Cure of recurrent ascites in alcoholic hepatitis following transient placement of a LeVeen shunt].
Yersin B; Genton A; Mosimann R; Magnenat P
Schweiz Med Wochenschr; 1989 May; 119(21):768-9. PubMed ID: 2756407
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of irreducible ascites of cirrhotic patients with peritoneo-jugular shunt].
Capussotti L; Aricò S; Marucci M; Dellepiane M; De La Pierre M
Minerva Med; 1982 Dec; 73(49-50):3477-84. PubMed ID: 7155396
[TBL] [Abstract][Full Text] [Related]
31. [Successful treatment for intractable ascites with uterine cancer using double Denver peritoneovenous shunt system].
Kawamoto J; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1919-23. PubMed ID: 17212147
[TBL] [Abstract][Full Text] [Related]
32. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.
Esteva-Font C; Baccaro ME; Fernández-Llama P; Sans L; Guevara M; Ars E; Jiménez W; Arroyo V; Ballarín JA; Ginès P
Hepatology; 2006 Dec; 44(6):1555-63. PubMed ID: 17133493
[TBL] [Abstract][Full Text] [Related]
33. PeriLeve: An Implantable Peritoneovesicular Biopowered Shunt to Manage Patients with Refractory Ascites.
Jain A; Scavo L; Cross D; Petney M; Garrett C; Marra SP; Nimgaonkar A
Gastroenterology; 2019 Jul; 157(1):21-22. PubMed ID: 31077721
[No Abstract] [Full Text] [Related]
34. Fatal air embolism following perforation of the cecum in a patient with peritoneovenous shunt for ascites.
Hirst AE; Saunders FC
Am J Gastroenterol; 1981 Nov; 76(5):453-5. PubMed ID: 7337135
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic umbilical hernia repair in a cirrhotic patient with a peritoneovenous shunt.
Umemura A; Suto T; Sasaki A; Fujita T; Endo F; Wakabayashi G
Asian J Endosc Surg; 2015 May; 8(2):212-5. PubMed ID: 25418015
[TBL] [Abstract][Full Text] [Related]
36. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
37. Use of extracorporeal ascites dialysis in combined hepatic and renal failure.
Adler AJ; Feldman J; Friedman EA; Berlyne GM
Nephron; 1982; 30(1):31-5. PubMed ID: 7088230
[No Abstract] [Full Text] [Related]
38. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
Orloff MJ; Orloff MS; Orloff SL; Girard B
J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
[TBL] [Abstract][Full Text] [Related]
39. Antibodies reduce endotoxin threat after ascites shunt.
Hosp Pract; 1978 Jul; 13(7):32. PubMed ID: 751875
[No Abstract] [Full Text] [Related]
40. Peritoneo-venous shunting and endoscopic sclerotherapy in patients with portal hypertension.
Söderlund C; Eriksson LS; Seligson U
Ann Chir Gynaecol; 1986; 75(6):319-24. PubMed ID: 3495219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
